OncoMatch/Clinical Trials/NCT02064673
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Is NCT02064673 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Curcumin for prostate cancer.
Treatment: Curcumin — This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Prostate Cancer
Disease stage
Required: Stage PT1, PT2, PT3
Grade: Gleason 6Gleason 7 (Gleason)
pathologically confirmed T1-T3 disease; pT1-pT3pNxMx; This includes patients with Gleason 6 or 7(T2 disease)
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Demographics
Prior therapy
Must have received: radical prostatectomy
Status post radical prostatectomy for histologically confirmed adenocarcinoma of the prostate
Cannot have received: hormone therapy
hormone therapy before surgery
Cannot have received: radiation therapy
radiation therapy as primary treatment after surgery
Lab requirements
Blood counts
ANC ≥ 1.5 x 10^3/uL, platelets ≥ 50 x K/uLL, hemoglobin ≥ 10 g/dL
Kidney function
serum creatinine <2mg/dl
Liver function
bilirubin ≤ 1.5 mg/dl; AST/ALT < 2x ULN
adequate renal and liver function as well as bone marrow reserve (measured serum creatinine <2mg/dl, bilirubin ≤ 1.5 mg/dl, ANC ≥ 1.5 x 10 (3) uL, platelets ≥ 50 x K/uLL, and hemoglobin ≥ 10 g/dL); AST/ALT are equal or greater than 2 times the upper limit of normal [excluded]
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- UT Southwestern Medical Center · Dallas, Texas
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT02064673 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior hormone therapy, radiation therapy disqualifies patients from enrollment.
What disease stage is eligible?
Stage PT1 or PT2 or PT3 is required.
Is there an age limit?
Yes. Patients must be 80 years or younger and at least 30 years old.
Is this trial open to female patients?
No. This trial enrolls male patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages